Market watch: Forecasting market share in the US pharmaceutical market

Drug development is costly, so drug makers need accurate estimates of sales potential. However, sales forecasts are often unreliable. Here, we present an analysis of data concerning entry order and promotional spending from a large sample of drug classes, to estimate peak market share while controlling for product quality.